Otsuka says Phase 3b study shows SIMTRIYO improves ADHD and anxiety scores in adults with comorbid anxiety disorders
Otsuka presented new Phase 3b analyses at Psych Congress 2026 on SIMTRIYO (centanafadine) in adults with ADHD plus anxiety disorders. Expanded results built on topline findings released in June, showing consistent symptom improvement across clinician-rated and patient-reported measures. Data also pointed to gains in da